30
Participants
Start Date
June 30, 2012
Primary Completion Date
November 30, 2012
Study Completion Date
November 30, 2012
AZD8683
Multiple dose, oral inhalation (Healthy volunteers) Multiple dose, oral inhalation (COPD patients)
Placebo
Multiple dose, oral inhalation (Healthy volunteers) Multiple dose, oral inhalation (COPD patients
London
Lead Sponsor
AstraZeneca
INDUSTRY